Ro has raised $1B across 5 funding rounds, plus 1 undated round. The latest round valued Ro at $7B post-money, with ShawSpring Partners on the lead line.
Ro raised $3.1 million in a 2017 seed round led by General Catalyst, then $88 million in a 2018 Series A led by FirstMark Capital and $200 million in a 2020 Series C. In March 2021 it raised a $500 million Series D led by General Catalyst, FirstMark Capital, and TQ Ventures, valuing the company at $5 billion.
5 funding rounds, the latest highlighted.
Ro was founded in 2017, United States.
No date is disclosed for this round.
A primary round — the company sells new shares to investors it selects. $3.1M raised, led by General Catalyst.
A primary round — the company sells new shares to investors it selects. $88M raised, led by FirstMark Capital.
A primary round — the company sells new shares to investors it selects. $200M raised.
A primary round — the company sells new shares to investors it selects. $500M raised, led by General Catalyst, FirstMark Capital, TQ Ventures.
FirstMark Capital, General Catalyst, Seven Seven Six, BoxGroup, Altimeter Capital, Baupost Group, Initialized, TQ Ventures, TCG. $150M raised, led by ShawSpring Partners.
No filing has been made.
5 dated rounds, newest first.
FirstMarkLEADSShawSpring PartnersLEAD
General CatalystLEAD
FirstMark CapitalLEAD
TQ VenturesLEADThe routes section explains what is realistically available for a company at this stage.
No. Ro is a private company; its shares do not trade on a public exchange.
The last valuation is $5B.
Lead investors for each round are in the funding timeline.
The closest telehealth peers are on the competitors page.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
